Literature DB >> 27470352

Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes.

Fanqi Kong1, Bozhi Ye2, Lu Lin3, Xueli Cai4, Weijian Huang5, Zhouqing Huang6.   

Abstract

AIMS: Increasing evidence shows that NLRP3 inflammasome is closely associated with the progression of atherosclerosis. The purpose of the present study was to evaluate the effects of atorvastatin on NLRP3 inflammasome in PMA-stimulated THP-1 cells and explore its underlying mechanism.
METHODS: Human monocytic THP-1 cells were pretreated with atorvastatin for 1h and then induced by PMA for 48h. Total protein was collected for real-time PCR and Western blot analysis. Cytokine IL-1β release was detected by ELISA assay. And the NF-κB p65 translocation was detected by cellular NF-κB translocation kit.
RESULTS: It was shown that atorvastatin significantly reduced the expression of NLRP3, the cleavage of caspase-1 and IL-1β in PMA-induced THP-1 cells. Moreover, Bay (a NF-κB inhibitor) treatment greatly suppressed the expression of NLRP3, the cleavage of caspase-1 and IL-1β in PMA-induced THP-1 cells, suggesting that the activation of NF-κB pathway takes part in regulating the expression of NLRP3 inflammasome. In addition, atorvastatin markedly inhibited the up-regulation of toll-like receptor 4 (TLR4), myeloid differentiation factor 88 (MyD88) and the activation of nuclear factor kappa b (NF-κB) in PMA-stimulated THP-1 cells.
CONCLUSIONS: Atorvastatin exerts an anti-inflammatory effect by inhibiting NLRP3 inflammasome through suppressing TLR4/MyD88/NF-κB pathway in PMA-induced THP-1 monocytes.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Atorvastatin; Monocytes; NLRP3 inflammasome; TLR4/MyD88/NF-κB

Mesh:

Substances:

Year:  2016        PMID: 27470352     DOI: 10.1016/j.biopha.2016.04.043

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  35 in total

Review 1.  Mitochondrial DAMPs and altered mitochondrial dynamics in OxLDL burden in atherosclerosis.

Authors:  Bisma Khwaja; Finosh G Thankam; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2021-01-25       Impact factor: 3.396

2.  Potential role of BAY11-7082, a NF-κB blocker inhibiting experimental autoimmune encephalomyelitis in C57BL/6J mice via declining NLRP3 inflammasomes.

Authors:  Yue Lang; Fengna Chu; Lingling Liu; Chao Zheng; Chunrong Li; Donghui Shen; Shan Liu; Weiguanliu Zhang; Li Cui; Jie Zhu
Journal:  Clin Exp Immunol       Date:  2022-05-12       Impact factor: 4.330

3.  NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases.

Authors:  Weijia Cheng; Can Cui; Gang Liu; Chenji Ye; Fang Shao; Ashim K Bagchi; Jawahar L Mehta; Xianwei Wang
Journal:  Cardiovasc Drugs Ther       Date:  2022-07-07       Impact factor: 3.727

4.  Atorvastatin inhibited TNF-α induced matrix degradation in rat nucleus pulposus cells by suppressing NLRP3 inflammasome activity and inducing autophagy through NF-κB signaling.

Authors:  Jiancong Chen; Jiansen Yan; Shuangxing Li; Jianxiong Zhu; Jie Zhou; Jun Li; Yangyang Zhang; Zhengqi Huang; Liang Yuan; Kang Xu; Weijian Chen; Wei Ye
Journal:  Cell Cycle       Date:  2021-09-08       Impact factor: 5.173

Review 5.  Biological Actions, Implications, and Cautions of Statins Therapy in COVID-19.

Authors:  Chengyu Liu; Wanyao Yan; Jiajian Shi; Shun Wang; Anlin Peng; Yuchen Chen; Kun Huang
Journal:  Front Nutr       Date:  2022-06-22

6.  Medications Associated with Lower Mortality in a SARS-CoV-2 Positive Cohort of 26,508 Veterans.

Authors:  Christine M Hunt; Jimmy T Efird; Thomas S Redding; Andrew D Thompson; Ashlyn M Press; Christina D Williams; Christopher J Hostler; Ayako Suzuki
Journal:  J Gen Intern Med       Date:  2022-06-29       Impact factor: 6.473

7.  Potential role of BAY11-7082, a NF-κB blocker inhibiting experimental autoimmune encephalomyelitis in C57BL/6J mice via declining NLRP3 inflammasomes.

Authors:  Yue Lang; Fengna Chu; Lingling Liu; Chao Zheng; Chunrong Li; Donghui Shen; Shan Liu; Weiguanliu Zhang; Li Cui; Jie Zhu
Journal:  Clin Exp Immunol       Date:  2021-11-27       Impact factor: 5.732

8.  Mycoplasma pneumoniae lipids license TLR-4 for activation of NLRP3 inflammasome and autophagy to evoke a proinflammatory response.

Authors:  H Luo; J He; L Qin; Y Chen; L Chen; R Li; Y Zeng; C Zhu; X You; Y Wu
Journal:  Clin Exp Immunol       Date:  2020-09-29       Impact factor: 4.330

Review 9.  MyD88: At the heart of inflammatory signaling and cardiovascular disease.

Authors:  Abraham L Bayer; Pilar Alcaide
Journal:  J Mol Cell Cardiol       Date:  2021-08-08       Impact factor: 5.000

Review 10.  From Mitochondria to Atherosclerosis: The Inflammation Path.

Authors:  Juan M Suárez-Rivero; Carmen J Pastor-Maldonado; Suleva Povea-Cabello; Mónica Álvarez-Córdoba; Irene Villalón-García; Marta Talaverón-Rey; Alejandra Suárez-Carrillo; Manuel Munuera-Cabeza; José A Sánchez-Alcázar
Journal:  Biomedicines       Date:  2021-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.